Atlas Trials

Safety and Efficacy Evaluation of LC-K76 in Patients With Metastatic Hormone-Sensitive Prostate Cancer

Clinical trial NCT07389174 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07389174
Sponsor
Shanghai Changzheng Hospital
Status
NOT_YET_RECRUITING
Phase
Early Phase 1
Study type
INTERVENTIONAL
mHSPCmHNPCProstate Cancer Adenocarcinoma
Start date
2026-02-01
Primary completion
2027-01-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.